The General Election announced for July, with purdah pre-election and consequent changes in people and policy after, is a source of further uncertainty for the NHS.
This comes as the health service was already facing a period of significant change, and this rapidly shifting landscape creates major challenges for pharma.
There were already big challenges within the healthcare system in England and a likely change of government (if the polls are to be believed) will ramp up the pressure on an NHS already facing some significant difficulties.
Check out the rest of the feature here
